|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_ocn868971939 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
131108s2012 gw acd ob 100 0 eng d |
040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d OCLCO
|d N$T
|d OCLCF
|d OCL
|d CWR
|d OCLCQ
|d COCUF
|d AGLDB
|d MOR
|d PIFAG
|d OCLCQ
|d U3W
|d STF
|d CUY
|d VTS
|d OCLCQ
|d M8D
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 961590682
|a 962697906
|
020 |
|
|
|a 9781847357243
|q (electronic bk.)
|
020 |
|
|
|a 1847357245
|q (electronic bk.)
|
020 |
|
|
|z 9781847357236
|
029 |
1 |
|
|a AU@
|b 000053309874
|
029 |
1 |
|
|a DEBBG
|b BV043039328
|
029 |
1 |
|
|a DEBSZ
|b 429974590
|
029 |
1 |
|
|a GBVCP
|b 813233798
|
029 |
1 |
|
|a NZ1
|b 15590163
|
035 |
|
|
|a (OCoLC)868971939
|z (OCoLC)961590682
|z (OCoLC)962697906
|
050 |
|
4 |
|a RA1224.2
|b .E53 2012eb
|
072 |
|
7 |
|a PHI
|x 005000
|2 bisacsh
|
082 |
0 |
4 |
|a 178
|
049 |
|
|
|a UAMI
|
111 |
2 |
|
|a Endocrine Disruptors
|d (2012 :
|c Munich, Germany)
|j issuing body.
|
245 |
1 |
0 |
|a Endocrine Disruptors 2012 :
|b [conference proceedings] : Munich, Germany, 14-15 February 2012 /
|c organised by Smithers.
|
264 |
|
1 |
|a Munich :
|b Smithers Rapra Technology Limited,
|c 2012.
|
300 |
|
|
|a 1 online resource (178 pages) :
|b illustrations, portraits
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a "14-15 February 2012, Hotel Eurostars Grand Central, Munich"--Cover
|
504 |
|
|
|a Includes bibliographical references.
|
588 |
0 |
|
|a Online resource; title from PDF title page (ebrary, viewed November 8, 2013).
|
505 |
0 |
|
|a 9781847357236_FrontCover; Contents; Session 1: Regulatory Aspects; Paper 1 EU's approach to the regulation of endocrine disruptors; Paper 2 OECD activities on endocrine disruptors testing and assessment; Session 2: Test Strategies and Methods; Paper 3 The evaluation of control performance in the amphibian metamorphosis assay (OPPTS 890.1100) and in the fish short-; Paper 4 Endocrine Disruptors -- Guidance to clients on their testing strategies: difficulties and constraints; Paper 5 Evaluation and lessons learned in the in vitro tier 1 endocrine disruption screening assays.
|
505 |
8 |
|
|a Paper 6 Lack of androgenicity and estrogenicity of the three monomers used in Eastman's co-polyesterPaper 7 Endocrine disruption in aquatic environment from mechanistic to predictive approach; Paper 8 Pharmacophore models for predicting endocrine disrupting effects of xenobiotics: concept and case studies on steroid ; Paper 9 Bioassays for the identification of xenobiotics interfering with.
|
520 |
|
|
|a Following on from the highly successful inaugural 2011 conference which took place in Switzerland, Endocrine Disruptors 2012 addressed key topics related to the evaluation of adverse effects on the endocrine system and corresponding regulatory requirements. These proceedings contain all the presentations from this conference which brought together experts from academia, government, and industry from around the globe to focus on current and future trends in testing, interpretation and evaluation of test results and how this relates to or influences regulatory activities.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Endocrine disrupting chemicals
|v Congresses.
|
650 |
|
6 |
|a Perturbateurs endocriniens
|v Congrès.
|
650 |
|
7 |
|a PHILOSOPHY
|x Ethics & Moral Philosophy.
|2 bisacsh
|
650 |
|
7 |
|a Endocrine disrupting chemicals
|2 fast
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
710 |
2 |
|
|a Smithers.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=653181
|z Texto completo
|
936 |
|
|
|a BATCHLOAD
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10785166
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 653181
|
994 |
|
|
|a 92
|b IZTAP
|